Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction

被引:35
作者
Lambert, Nathan D. [1 ]
Sacrinty, Matthew T. [1 ]
Ketch, Terry R. [1 ]
Turner, Samuel J. [1 ]
Santos, Renato M. [1 ]
Daniel, Kurt R. [1 ]
Applegate, Robert J. [1 ]
Kutcher, Michael A. [1 ]
Sane, David C. [1 ]
机构
[1] Wake Forest Univ, Sch Med, Cardiol Sect, Winston Salem, NC 27157 USA
关键词
CARDIOVASCULAR OUTCOMES; MICROALBUMINURIA; ASSOCIATION; IMPLANTATION; ALBUMINURIA; DYSFUNCTION; PREVALENCE; EVENTS; TRIALS;
D O I
10.1016/j.ahj.2009.01.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Kidney failure (stage 5 chronic kidney disease [CKD]) is an independent risk factor for stent thrombosis (ST). Moderate (stage 3-4) CKD and proteinuria are both associated with adverse cardiovascular events, including worse outcomes after myocardial infarction (MI). Whether moderate CKD and proteinuria increase the risk of ST after MI is not known. This study evaluated the risk of ST associated with moderate CKD and dipstick proteinuria. Methods We retrospectively analyzed clinical and laboratory data from 956 non-stage 5 CKD patients who were admitted with MI and received intracoronary stenting. Clinical follow-up was collected at 1 year for definite or probable ST, as well as for all-cause mortality, nonfatal MI or death, and target vessel revascularization or coronary artery bypass graft surgery. Results After adjustment for multiple clinical and biochemical covariates, patients with both estimated glomerular filtration rate (GFR) of 15 to 59 mL min(-1) 1.73 m(-2) and >= 30 mg/dL dipstick proteinuria had increased cumulative incidence of ST (hazard rate [HR] 3.69, 95% CI 1.54-8.89), all-cause mortality (HR 2.68, 95% Cl 1.34-5.37), and nonfatal MI or death (HR 3.20, 95% CI 1.77-5.81) at 1 year. In addition, estimated GFR of 15 to 59 mL min(-1) 1.73 m(-2) was a significant independent predictor of ST (HR 2.61, 95% Cl 1.33-5.10). Dipstick proteinuria >= 30 mg/dL was associated with a trend toward increased risk for all outcomes. Conclusions In an acute MI population, moderate CKD was identified as a novel prognostic marker for ST. In addition, patients with both decreased GFR and proteinuria had higher incidences of all-cause mortality and nonfatal MI or death than patients with either condition alone. (Am Heart J 2009; 157:688-94.)
引用
收藏
页码:688 / 694
页数:7
相关论文
共 30 条
  • [1] Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
  • [2] ACC/AHA 2007 guide lines for the management of patients with unstable Angina/Non-ST-Elevation myocardial infraction - Executive summary
    Anderson, Jeffrey L.
    Adams, Cynthia D.
    Antman, Elliott M.
    Bridges, Charles R.
    Califf, Robert M.
    Casey, Donald E., Jr.
    Chavey, William E., II
    Fesmire, Francis M.
    Hochman, Judith S.
    Levin, Thomas N.
    Lincoff, A. Michael
    Peterson, Eric D.
    Theroux, Pierre
    Wenger, Nanette Kass
    Wright, R. Scott
    Smith, Sidney C., Jr.
    Jacobs, Alice K.
    Adams, Cynthia D.
    Riegel, Barbara
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (07) : 652 - 726
  • [3] Off-label stent therapy - 2-year comparison of drug-eluting versus bare-metal stents
    Applegate, Robert J.
    Sacrinty, Matthew T.
    Kutcher, Michael A.
    Santos, Renato M.
    Gandhi, Sanjay K.
    Baki, Talal T.
    Little, William C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (06) : 607 - 614
  • [4] Urine proteomics: the present and future of measuring urinary protein components in disease
    Barratt, Jonathan
    Topham, Peter
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 177 (04) : 361 - 368
  • [5] Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of bate thrombosis
    Bavry, Anthony A.
    Bhatt, Deepak L.
    [J]. LANCET, 2008, 371 (9630) : 2134 - 2143
  • [6] Renal albumin absorption in physiology and pathology
    Birn, H
    Christensen, E
    [J]. KIDNEY INTERNATIONAL, 2006, 69 (03) : 440 - 449
  • [7] Prevalence of chronic kidney disease in the United States
    Coresh, Josef
    Selvin, Elizabeth
    Stevens, Lesley A.
    Manzi, Jane
    Kusek, John W.
    Eggers, Paul
    Van Lente, Frederick
    Levey, Andrew S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (17): : 2038 - 2047
  • [8] Cutlip DE, 2001, CIRCULATION, V103, P1967
  • [9] Clinical end points in coronary stent trials - A case for standardized definitions
    Cutlip, Donald E.
    Windecker, Stephan
    Mehran, Roxana
    Boam, Ashley
    Cohen, David J.
    van Es, Gerrit-Anne
    Steg, P. Gabriel
    Morel, Marie-angele
    Mauri, Laura
    Vranckx, Pascal
    McFadden, Eugene
    Lansky, Alexandra
    Hamon, Martial
    Krucoff, Mitchell W.
    Serruys, Patrick W.
    [J]. CIRCULATION, 2007, 115 (17) : 2344 - 2351
  • [10] Drug-eluting stent thrombosis -: Results from the Multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos)
    de la Torre-Hernandez, Jos M.
    Alfonso, Fernando
    Hernandez, Felipe
    Elizaga, Jaime
    Sanmartin, Marcelo
    Pinar, Eduardo
    Lozano, Inigo
    Vazquez, Jose M.
    Botas, Javier
    Perez de Prado, Armando
    Hernandez, Jose M.
    Sanchis, Juan
    Ruiz Nodar, Juan M.
    Gomez-Jaume, Alfredo
    Larman, Mariano
    Diarte, Jose A.
    Rodriguez-Collado, Javier
    Rumoroso, Jose R.
    Lopez-Minguez, Jose R.
    Mauri, Josepa
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : 986 - 990